Research and Practice in Thrombosis and Haemostasis, published by Elsevier, is a prominent open-access journal dedicated to advancing the field of hematology through high-quality research and clinical practice. Since its inception in 2017, this journal has established itself as a vital resource for researchers, healthcare professionals, and students interested in thrombosis and hemorrhage management, showcasing original research, reviews, and clinical studies. The journal’s commitment to accessible knowledge is reflected in its open-access model, allowing researchers worldwide to share their findings without financial barriers. With an impressive 2023 Scopus rank of #42 out of 137 in the hematology category and a respectable Q2 classification, it provides an authoritative platform for innovative ideas and cutting-edge developments in the field. As the journal continues to grow in stature, it aims to foster collaboration and knowledge exchange amongst professionals dedicated to improving patient outcomes in thrombosis and hemostasis.

The International Journal of Vascular Medicine is a peer-reviewed, open access journal dedicated to advancing research and knowledge in the field of vascular medicine. Published by HINDAWI LTD and operating since 2010, this journal provides a platform for the dissemination of high-quality studies, reviews, and case reports related to cardiovascular health. Based in Egypt, the journal's comprehensive scope encompasses a range of topics within cardiology and cardiovascular medicine, with a current impact factor reflected by its Q3 ranking in 2023, positioning it among the noteworthy publications in its category. With a Scopus rank of 176 out of 387, the journal maintains a significant presence in the academic community, supported by a commitment to open access, ensuring that research is freely available to all stakeholders. Researchers, professionals, and students alike are encouraged to contribute to and engage with the International Journal of Vascular Medicine as it enhances the understanding and treatment of vascular diseases and promotes innovative practices within the field.

Visceral Medicine is a distinguished journal published by KARGER, specializing in the fields of gastroenterology and surgery. With an ISSN of 2297-4725 and an E-ISSN of 2297-475X, this journal has secured its place in the academic landscape since its inception in 2016, maintaining a consistent quality of research and fostering advancements in visceral health through the year 2024. With notable rankings within the 2nd quartile (Q2) for both gastroenterology and surgery categories, Visceral Medicine ranks #101 out of 551 in the Medicine & Surgery category and #67 out of 167 in Gastroenterology according to Scopus, reflecting its significant impact and relevance in the pursuit of scientific knowledge. Despite not being an open access journal, it provides valuable insights and original research aimed at professionals, researchers, and students keen on expanding their understanding of visceral diseases and innovative surgical techniques. The journal is headquartered in Basel, Switzerland, contributing to its reputation as a hub for high-quality scholarly communication within the medical community.

Angiologia, published by ARAN EDICIONES, S A, serves as a vital platform for the dissemination of research and advancements in the fields of cardiology and cardiovascular medicine. Established in 1949, this Spanish journal has made significant contributions to understanding vascular health, although it currently holds a Q4 status in Scopus rankings, indicating a critical opportunity for emerging researchers to contribute to this evolving field. Spanning from 1949 to 1993 and resuming from 1996 to 2024, the journal reflects a rich history of academic discourse. With its ISSN 0003-3170 and E-ISSN 1695-2987, Angiologia is committed to enhancing the visibility of cardiovascular research, providing access to a diverse range of articles that cater to the needs of healthcare professionals, academics, and students aiming to deepen their understanding of angiological health. While the journal currently does not offer open access options, it remains significant in guiding future research and fostering innovations within the cardiology landscape.

Blood and Lymphatic Cancer-Targets and Therapy, published by DOVE MEDICAL PRESS LTD, is a vital open-access journal that has been disseminating crucial research and findings in the field of hematology and oncology since 2011. With its ISSN 1179-9889, this journal focuses on the latest therapeutic targets and innovative treatment strategies for blood and lymphatic cancers, contributing significantly to the advancement of knowledge and practice in this specialized area. Designed for researchers, healthcare professionals, and students alike, Blood and Lymphatic Cancer-Targets and Therapy aims to foster a deeper understanding of cancer biology and promote collaborative efforts leading to novel therapeutic interventions. The open-access model ensures that research findings are readily accessible to a global audience, underscoring the journal's commitment to enhancing patient care and fostering educational growth in the cancer domain.

The Journal of Vascular Surgery-Venous and Lymphatic Disorders, published by Elsevier, is a distinguished peer-reviewed journal dedicated to advancing the knowledge and practice of vascular surgery with a particular focus on venous and lymphatic conditions. With an ISSN of 2213-333X and a robust impact factor, this journal ranks Q2 in Cardiology and Cardiovascular Medicine and Q1 in Surgery, reflecting its high relevance and contribution to the field. Covering a wide spectrum of topics from innovative surgical techniques to the latest developments in venous and lymphatic disorders, the journal serves as a vital resource for researchers, clinicians, and students alike. It not only disseminates cutting-edge research but also promotes best practices and interdisciplinary collaboration within the cardiovascular domain. The journal is accessible to a global audience, ensuring that impactful findings reach practitioners and researchers everywhere, further elevating the standards of patient care and surgical excellence.

Techniques in Vascular and Interventional Radiology, published by Elsevier, is a distinguished journal dedicated to the rapidly evolving field of vascular and interventional radiology. With an ISSN of 1089-2516 and an E-ISSN of 1557-9808, this journal serves as a critical platform for disseminating innovative research and practical advancements in the diagnosis and management of vascular diseases. Operating from the United States, it has established a significant presence in the academic community, evidenced by its 2023 Scopus rankings placing it in the Q3 quartile for both Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. The journal aims to publish high-quality articles that encompass both clinical applications and novel technologies, making it an essential resource for researchers, clinicians, and students alike. With its commitment to fostering knowledge and collaboration in this vital area of medicine, Techniques in Vascular and Interventional Radiology plays a key role in advancing patient care and clinical practice.

Lymphatic Research and Biology, an esteemed journal published by MARY ANN LIEBERT, INC, plays a critical role in the exploration of lymphatic biology and its implications in cardiology and cardiovascular medicine. Established in 2003, this journal has dedicated itself to advancing our understanding of lymphatic function, disorders, and innovative therapeutic strategies, making it a significant resource for researchers and practitioners in the field. With an ISSN of 1539-6851 and an E-ISSN of 1557-8585, it provides a platform for cutting-edge research, reviews, and clinical studies aimed at bridging the gap between basic science and clinical applications. While currently not an open-access journal, it offers a wealth of knowledge pertinent to those involved in lymphatic health and cardiovascular research. With a 2023 Scopus ranking placing it in the second quartile (Q2) for Cardiology and Cardiovascular Medicine, this journal is poised to influence the next generation of scientific inquiry and practice.

LYMPHOLOGY is a distinguished journal dedicated to the study of lymphatic biology, hematology, and immunology, published by the esteemed LYMPHOLOGY organization since its inception in 1968. As a key resource within the scientific community, it holds a notable place in the academic landscape with a 2023 Scopus ranking of #47 in Hematology and #120 in Immunology and Allergy, reflecting its commitment to advancing knowledge through empirical research and critical reviews. Although it is not an Open Access journal, its relevance is underlined by a Q3 category in both hematology and immunology, providing a platform for groundbreaking research that addresses key challenges in these fields. Researchers and professionals will find invaluable insights and innovative methodologies within its pages, reinforcing its role as a vital contributor to advancing scientific understanding and clinical practice in lymphology and related disciplines.

PHLEBOLOGY is a renowned academic journal published by SAGE Publications Inc. that focuses on the evolving field of phlebology and related cardiovascular issues. With an ISSN of 0268-3555 and an E-ISSN of 1758-1125, this journal serves as a pivotal platform for disseminating high-quality research, clinical findings, and innovative practices in venous disease management and treatment. Operating from the United Kingdom, tasked with a mission to advance the scientific understanding and clinical practice surrounding venous disorders, PHLEBOLOGY is currently ranked in the Q3 category for both Cardiology and Cardiovascular Medicine, as well as in Medicine (miscellaneous) for 2023. Its Scopus rank of #192 out of 387 highlights its commitment to excellence, ensuring that it reaches a respectable 50th percentile within its fields. Although it does not offer open access, the journal invites contributions from researchers, healthcare professionals, and students, fostering a community dedicated to improving patient outcomes and promoting evidence-based practices in venous health.